[{"address1": "3710 \u2013 33rd Street NW", "city": "Calgary", "state": "AB", "zip": "T2L 2M1", "country": "Canada", "phone": "403 455 7727", "website": "https://www.xortx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease. Its drug development programs include XRx-026, which is in the third phase for the treatment of gout; XRx-008, which is in the second phase to treat autosomal dominant polycystic kidney disease; XRx-101, which is in the second phase to treat acute kidney injury associated with respiratory virus infection; and XRX-225, which is in the preclinical stage for the treatment of type 2 diabetic nephropathy. It has a license agreement with the University of Florida Research Foundation, Inc. for the use of uric acid lowering agent to treat insulin resistance. The company is based in Calgary, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Allen Warren Davidoff Ph.D.", "age": 65, "title": "Founder, CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 391655, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael Scott Bumby D.V.M., M.B.A.", "age": 61, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 6515, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Haworth M.D., MRCP", "age": 75, "title": "Chief Medical Officer", "yearBorn": 1950, "fiscalYear": 2024, "totalPay": 110445, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stacy  Evans M.B.A., M.D.", "age": 51, "title": "Chief Business Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 157500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Nick  Rigopoulos", "title": "Director of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Sans M.B.A., Ph.D.", "age": 55, "title": "Director of Corporate Development", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  MacDonald Ph.D.", "age": 62, "title": "Consultant of Clinical Operations", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Charlotte  May", "title": "Corporate Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.562, "open": 0.5691, "dayLow": 0.5658, "dayHigh": 0.6, "regularMarketPreviousClose": 0.562, "regularMarketOpen": 0.5691, "regularMarketDayLow": 0.5658, "regularMarketDayHigh": 0.6, "payoutRatio": 0.0, "beta": -0.104, "forwardPE": -1.6223627, "volume": 34920, "regularMarketVolume": 34920, "averageVolume": 2008643, "averageVolume10days": 54620, "averageDailyVolume10Day": 54620, "bid": 0.5807, "ask": 0.6661, "bidSize": 1, "askSize": 1, "marketCap": 3968464, "fiftyTwoWeekLow": 0.51, "fiftyTwoWeekHigh": 1.79, "allTimeHigh": 495.72, "allTimeLow": 0.51, "fiftyDayAverage": 0.6007, "twoHundredDayAverage": 0.8202, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2833643, "profitMargins": 0.0, "floatShares": 6253325, "sharesOutstanding": 6962218, "sharesShort": 35529, "sharesShortPriorMonth": 100562, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0050999997, "heldPercentInsiders": 0.10095, "heldPercentInstitutions": 0.04008, "shortRatio": 0.7, "shortPercentOfFloat": 0.0052, "impliedSharesOutstanding": 6962218, "bookValue": 0.379, "priceToBook": 1.5039577, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -1943307, "trailingEps": -0.4, "forwardEps": -0.35133943, "lastSplitFactor": "1:9", "lastSplitDate": 1699920000, "enterpriseToEbitda": -1.16, "52WeekChange": -0.5648855, "SandP52WeekChange": 0.14778805, "quoteType": "EQUITY", "currentPrice": 0.57, "targetHighPrice": 14.031766, "targetLowPrice": 14.031766, "targetMeanPrice": 14.031766, "targetMedianPrice": 14.031766, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 1193915, "totalCashPerShare": 0.171, "ebitda": -2443400, "totalDebt": 59094, "quickRatio": 1.452, "currentRatio": 1.621, "debtToEquity": 2.994, "returnOnAssets": -0.45321998, "returnOnEquity": -0.94628, "freeCashflow": -2335485, "operatingCashflow": -2953274, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "XRTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1632403800000, "corporateActions": [], "postMarketTime": 1767392558, "regularMarketTime": 1767387600, "exchange": "NCM", "messageBoardId": "finmb_259860883", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "XORTX Therapeutics Inc.", "longName": "XORTX Therapeutics Inc.", "postMarketChangePercent": -0.017546771, "postMarketPrice": 0.5699, "postMarketChange": -0.000100016594, "regularMarketChange": 0.00800002, "regularMarketDayRange": "0.5658 - 0.6", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2008643, "fiftyTwoWeekLowChange": 0.060000002, "fiftyTwoWeekLowChangePercent": 0.11764707, "fiftyTwoWeekRange": "0.51 - 1.79", "fiftyTwoWeekHighChange": -1.22, "fiftyTwoWeekHighChangePercent": -0.6815643, "fiftyTwoWeekChangePercent": -56.48855, "earningsTimestamp": 1763213400, "earningsTimestampStart": 1763213400, "earningsTimestampEnd": 1763213400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.4, "epsForward": -0.35133943, "epsCurrentYear": -1.307, "priceEpsCurrentYear": -0.4361132, "fiftyDayAverageChange": -0.030700028, "fiftyDayAverageChangePercent": -0.051107086, "twoHundredDayAverageChange": -0.25020003, "twoHundredDayAverageChangePercent": -0.30504757, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-13", "regularMarketChangePercent": 1.42349, "regularMarketPrice": 0.57, "marketState": "CLOSED", "displayName": "XORTX Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-03"}]